Encorafenib
LGX818 is an orally available mutated BRaf V600E inhibitor (IC50=0.3 nM) with potential antineoplastic activity.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
540.01
Molecular Formula
C22H27ClFN7O4S
Notes
Research use only, not for human use.
Receptor
B-Raf (V600E)
CAS Number
1269440-17-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1169182 Inquire
Recombinant Schizosaccharomyces pombe SNF1-like protein kinase ssp2 (ssp2), partial
Ask
View Details 
